Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain

Journal of Nuclear Cardiology

Volumn 6, Issue 6, 1999, Pages 559-569

  Shaw, Leslee J ^a   Heller, Gary V ^b   Travin, Mark I ^c   Lauer, Michael ^d   Marwick, Thomas ^d   Hachamovitch, Rory ^e   Berman, Daniel S ^f   Miller, D Douglas ^g  

^a EMORY UNIVERSITY   (United States)

^b HARTFORD HOSPITAL   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e WEILL CORNELL MEDICAL CENTER   (United States)

^f CEDARS SINAI MEDICAL CENTER   (United States)

^g SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary artery disease; Cost; Diagnostic testing; Myocardial imaging; Patient outcomes

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; COST BENEFIT ANALYSIS; COST CONTROL; DIAGNOSTIC TEST; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART CATHETERIZATION; HEART DEATH; HEART MUSCLE PERFUSION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; THORAX PAIN; TREATMENT OUTCOME;

EID: 0033402750     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(99)90091-0     Document Type: Article

References (42)

1. Roper WL, Winkenwerder W, Hackbarth GM, Krakauer H. Effectiveness in health care: in initiation to evaluate and improve medical practice. N Engl J Med 1988;319:1197-202.
2. Ellwood P. Special report: Shattuck lecture-outcomes management. A technology of patient experience. N Engl J Med 1988;318:1549-56.
3. Patterson RE, Eisner RL, Horowitz SF. Comparison of cost-minimization and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation 1995;91:54-65.
4. Gould KL, Goldstein RA, Mullani NA. Economic analysis of clinical positron emission tomography of the heart with rubidium-82. J Nucl Med 1989;30:707-17.
5. Cerqueira MD. Diagnostic testing strategies for coronary artery disease: Specific issues related to gender. Am J Cardiol 1995;75:52D-60.
6. Johnson LL. Sex specific issues related to nuclear cardiology. J Nucl Cardiol 1995;2:339-48.
7. Shaw LJ, Miller DD, Romeis JC, Kargl D, Younis LT, Chaitman BR. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med 1994;120:559-66.
8. Williams MJ, Marwick TH, O'Gorman D, Foale RA. Comparison of exercise echocardiography with an exercise score to diagnose coronary artery disease in women. Am J Cardiol 1994;74:435-8.
9. Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy of T1-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997;29:69-77.
10. Marwick TH, Anderson T, Williams MJ, Haluska B, Melin JA, Pashkow F, et al. Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol 1995;26:335-41.
11. Society for the Advancement of Women's Health Research Report. Women's health research in a changing health care environment. The impact of managed care on women's health research. 1998.
12. Pryor DB, Shaw L, McCants CB, Lee KL, Mark DB, Harrell FE Jr, et al. Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med 1993;118:81-90.
13. Pryor DB, Harrell FE Jr, Lee KL, Califf RM, Rosati RA. Estimating the likelihood of significant coronary artery disease. Am J Med 1993; 75:771-80.
14. Pryor DB, Shaw L, Harrell FE, Lee KL, Hlatky MA, Mark DB, et al. Estimating the likelihood of severe coronary artery disease. Am J Med 1991;90:553-62.
15. Shaw LJ, Kesler KL, Hachamovitch R, Eisenstein EL, Heller GV, Miller DD. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part I. J Nucl Cardiol 1996;3:538-45.
16. Shaw LJ, Eisenstein EL, Hachamovitch R, Heller GV, Miller DD. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology. Part II. J Nucl Cardiol 1997;4:52-60.
17. Mark DB, Hlatky MA, Califf RM, et al. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med 1995;332:1418-24.
18. Patterson RE, Eisner RLL, Horowitz SF. Comparison of cost-minimization and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation 1995;91:54-65.
19. Kong BA, Shaw LJ, Miller DD, Chaitman BR. Comparison of accuracy for detecting coronary artery disease and side effect profile of dipyridamole thallium-201 myocardial perfusion imaging in women versus men. Am J Cardiol 1992;70:168-73.
20. Levit KR, Lazenby HC, Sivarajan L. Health care spending in 1994: slowest in decades. Health Affairs 1996;15:131-44.
21. Marcus R, Lowe R III, Froelicher VF, Do D. The exercise test as a gatekeeper. Limiting access or appropriately directing resources? Chest 1995;107:1442-6.
22. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992;146;473-81.
23. Fetters JK, Peterson ED, Shaw LJ, Newby LK, Califf RM. Gender-specific differences in coronary artery disease risk factors, evaluation and treatment: have they been adequately evaluated? Am Heart J 1996;131:796-813.
24. Mark DB, Shaw LK, DeLong ER, Califf RM, Pryor DB. Absence of gender bias in the referral of patients for cardiac catheterization. N Engl J Med 1994;330:1101-6.
25. Douglas PS, Ginsburg GS. The evaluation of chest pain in women. N Engl J Med 1996;334:1311-5.
26. Shaw LJ, Miller DD, Gillespie KN, Younis LT, Chaitman BR, Romeis JC. A gender-specific hazard-based clinical and noninvasive coronary risk scoring system for patients with suspected coronary artery disease. Clinical Performance and Quality Health Care 1995;3:209-17.
27. Okin PM, Kligfield P. Gender-specific criteria and performance of the exercise electrocardiogram. Circulation 1995;92:1209-16.
28. Wennberg DE, Kellett MA, Dickens JD, Malenka DJ, Keilson LM, Keller RB. The association between local diagnostic testing intensity and invasive cardiac procedures. J Am Med Assoc 1996;275;1161-4.
29. Goldman L, Garber AM, Grover SA, Hlatky MA. 27th Bethesda conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 6. Cost effectiveness of assessment and management of risk factors [review]. J Am Coll Cardiol 1996;27:1020-30.
30. Kahn KL, Kosecoff J, Chassin MR, Flynn MF, Fink A, Pattaphongse N, et al. Measuring the clinical appropriateness of the use of a procedure. Can we do it? Medical Care 1988;26:415-22.
31. Shaw LJ, Kesler K, Peterson ED, Borges-Neto S, Califf RM. Long-term prognostic implications of abnormal stress electrocardiographic or myocardial perfusion scintigraphic measures in patients with angiographically insignificant coronary artery disease [abstract]. J Am Coll Cardiol 1996;27:78A.
32. Reference deleted by author.
33. Peterson ED, Shaw LJ, Oddone E. An empirical approach to evaluation of chest pain in women. J Clin Outcomes 1996;2:9-23.
34. Brown KA. Prognostic value of thallium-201 perfusion imaging; a diagnostic tool comes of age. Circulation 1991;83:363-81.
35. Heller GV, Brown KA. Prognosis of acute and chronic coronary artery disease by myocardial perfusion imaging. Cardiol Clin 1994;12:271-87.
36. Stratmann HG, Williams GA, Wittry MD, Chaitman BR, Miller DD. Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation 1994;89:615-22.
37. Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease; a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995;26:639-47.
38. 1997 Heart and Stroke Statistical Update, http://www.amhrt.org/statistics/index.html.
39. Hendel RC, Chen MH, L'Italien GJ, Newell JB, Paul SD, Eagle KA, et al. Sex differences in perioperative and long-term cardiac event-free survival in vascular surgery patients. Circulation 1995;91:1044-51.
40. Travin MI, Duca MD, Kline GM, Herman SD, Demus DD, Heller GV. Relation of gender to physician use of test results and to the prognostic value of stress technetium-99m sestamibi myocardial single-photon emission computed tomography scintigraphy. Am Heart J 1997; 134:73-82.
41. Higgins M. How to estimate and reduce coronary heart disease in women. Cardiol Rev 1997;5:198-206.
42. Miller DD, Gersh BJ. Risk sensitive therapeutic strategies for coronary artery disease: towards testing-driven therapy in stable angina patients with a low-intermediate risk cardiac imaging study. J Nucl Cardiol 1997;4:409-17.